We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$24.6B
AUM Growth
+$2.47B
(+11%)
Cap. Flow
+$186M
Cap. Flow
% of AUM
0.76%
Top 10 Holdings %
Top 10 Hldgs %
25.43%
Holding
1,038
New
49
Increased
357
Reduced
452
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$131M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$116M |
| 3 |
Visa
V
|
+$111M |
| 4 |
Home Depot
HD
|
+$85.9M |
| 5 |
S&P Global
SPGI
|
+$82.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$43M |
| 2 |
West Pharmaceutical
WST
|
+$42.6M |
| 3 |
Church & Dwight Co
CHD
|
+$40.9M |
| 4 |
Fair Isaac
FICO
|
+$39.7M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$37.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.11% |
| 2 | Financials | 13.59% |
| 3 | Healthcare | 12.97% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
MetLife
MET
$62.1B
| $18.9M | 0.08% |
334,709
+251,415
| +302% | +$14M |
|
302
Factset
FDS
$10.2B
| $18.9M | 0.08% |
47,086
+43,976
| +1,414% | +$17.7M |
|
303
Alcoa
AA
$13.2B
| $18.7M | 0.08% |
550,065
+508,888
| +1,236% | +$18.5M |
|
304
Cencora
COR
$61.2B
| $18.4M | 0.07% |
95,459
+33,078
| +53% | +$5.72M |
|
305
Fox Class B
FOX
$23.9B
| $18.3M | 0.07% |
575,326
+515,694
| +865% | +$15.6M |
|
306
Open Text
OTEX
$6.04B
| $18.2M | 0.07% |
438,075
-150,223
| -26% | -$6.03M |
|
307
Truist Financial
TFC
$64B
| $18.1M | 0.07% |
597,352
-247,604
| -29% | -$7.69M |
|
|
HOLX
308
DELISTED
Hologic
HOLX
| $18M | 0.07% |
222,747
-328,805
| -60% | -$26.9M |
|
309
Cintas
CTAS
$81.3B
| $18M | 0.07% |
144,804
-13,248
| -8% | -$1.55M |
|
310
Stellantis
STLA
$20.8B
| $17.9M | 0.07% |
1,020,520
-581,089
| -36% | -$9.75M |
|
311
Humana
HUM
$46.2B
| $17.8M | 0.07% |
39,884
-2,334
| -6% | -$1.17M |
|
|
BKI
312
DELISTED
Black Knight, Inc. Common Stock
BKI
| $17.7M | 0.07% |
296,745
-223,110
| -43% | -$12.5M |
|
313
Seagate
STX
$184B
| $17.6M | 0.07% |
284,502
+208,014
| +272% | +$12.7M |
|
314
Warner Bros
WBD
$67.1B
| $17.6M | 0.07% |
1,400,608
-333,988
| -19% | -$4.33M |
|
315
Cleveland-Cliffs
CLF
$6.99B
| $17.4M | 0.07% |
1,040,951
-141,094
| -12% | -$2.24M |
|
316
PPG Industries
PPG
$26.6B
| $17.1M | 0.07% |
115,101
-53,620
| -32% | -$7.48M |
|
317
APA Corp
APA
$13.2B
| $17M | 0.07% |
496,715
+87,430
| +21% | +$3.05M |
|
|
318
McCormick & Company Non-Voting
MKC
$14.2B
| $16.8M | 0.07% |
192,482
-421,726
| -69% | -$37.3M |
|
319
Grab
GRAB
$14.9B
| $16.7M | 0.07% |
4,876,020
-503,066
| -9% | -$1.57M |
|
320
Simon Property Group
SPG
$72.3B
| $16.7M | 0.07% |
144,557
+50,176
| +53% | +$5.47M |
|
321
Cboe Global Markets
CBOE
$29.9B
| $16.4M | 0.07% |
118,507
-58,318
| -33% | -$7.96M |
|
322
Biogen
BIIB
$30.7B
| $16.3M | 0.07% |
57,261
+24,493
| +75% | +$7.29M |
|
323
Estee Lauder
EL
$32B
| $16.2M | 0.07% |
82,276
+48,656
| +145% | +$10.3M |
|
324
Steris
STE
$23.1B
| $16.1M | 0.07% |
71,732
-78,046
| -52% | -$15.6M |
|
325
Huntington Bancshares
HBAN
$35.5B
| $16.1M | 0.07% |
1,494,936
-263,402
| -15% | -$2.81M |
|
Similar funds
QCM
NAMI
Aviva's Q2 2023 Portfolio in Review
As of Q2 2023, Aviva held 1,038 positions worth $24.6B, up 11% from $22.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Aviva's Q2 2023 filing shows 49 new, 357 increased, 452 reduced and 75 closed positions. Its largest new stake was ATS Corp: 438,979 shares worth $20.2M. The largest sale was Marathon Petroleum, an estimated $43M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- Aviva's largest Q2 2023 buy was ATS Corp: 438,979 shares worth $20.2M.
- Aviva added most to ExxonMobil in Q2 2023, an estimated $131M increase.
- Aviva's biggest Q2 2023 reduction was Marathon Petroleum, cutting an estimated $43M.
- Aviva fully exited United Therapeutics in Q2 2023, selling an estimated $20.4M.
- Aviva's ten largest holdings make up 25% of its $24.6B portfolio in Q2 2023.
- Aviva opened 49 new positions and closed 75 in Q2 2023.
- Aviva's portfolio value rose 11% quarter-over-quarter to $24.6B.
Based on Aviva's 13F filing for Q2 2023, filed 10 Aug 2023.